Market revenue in 2021 | USD 7.3 billion |
Market revenue in 2030 | USD 11.7 billion |
Growth rate | 5.3% (CAGR from 2021 to 2030) |
Largest segment | Anti-hypertensive |
Fastest growing segment | Hormones |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD billion |
Market segmentation | Alkylating Agents, Antimetabolites, Hormones, Anti-hypertensive, Lipid Lowering drugs, Anti-depressants, Anti-psychotics, Anti-epileptics |
Key market players worldwide | Teva Pharmaceutical Industries Ltd, Lupin, Sanofi SA, Sun Pharmaceutical Industries, Dr. Reddy’s Laboratories, GlaxoSmithKline, Pfizer Inc, Apotex Inc., Viatris Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to branded generics market will help companies and investors design strategic landscapes.
Anti-hypertensive was the largest segment with a revenue share of 15.07% in 2021. Horizon Databook has segmented the Germany branded generics market based on alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptics covering the revenue growth of each sub-segment from 2018 to 2030.
The branded generic market in Germany is expected to witness positive growth over the forecast period due to government funding and investments to support generic drug manufacturing.
According to a study published in 2020, the country depends on 63% of APIs imported from Asian countries and 33% from European countries for manufacturing of generic products.
In Germany, there is high penetration of generics and fierce competition among the players. Germany is among the mature players in the EU with penetration of generics at about 35% by value and around 75% by volume.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany branded generics market , including forecasts for subscribers. This country databook contains high-level insights into Germany branded generics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account